Tyrosine kinase inhibitors
US8815906B2 · kind B2 · utility
29Cited by
14References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2009 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Oct 26, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4545
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compounds of the formula (I): or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.